PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478651
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478651
The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report "Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.
As per the data published by the American Heart Association (AHA), around 8.5 Mn adults in the U.S. are suffering from Peripheral Arterial Disease (PAD). PAD blocks iliac arteries; therefore, iliac stenting is required for smoother heart functioning.
In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.
In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.
For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.
Self-expandable stents segment dominated the market owing to various studies demonstrated self-expanding stents are commonly used for iliac artery occlusions.
Balloon-expandable stents segment expected to grow at the fastest rate, due to its capabilities such as severe radial outward force, and ability to accurately place stents.
Complete obstructive lesion segment expected to grow at the fastest rate due to rising the incidence of PAD, advancements in medicine, and cardiovascular diseases.
North America dominated the iliac stents market due to the rising incidence of PAD and rising older population and increasing risk factors such as diabetic and obesity
The key market players include Abbott, BD, Biotronik SE & Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, and Terumo Corporation.
Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region: